{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:51:44Z","timestamp":1791082304823,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jdcr.2025.02.024","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:27:16Z","timestamp":1741710436000},"page":"95-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adjunctive anifrolumab for recalcitrant discoid lupus erythematosus in the setting of systemic lupus erythematosus: A case report"],"prefix":"10.1016","volume":"60","author":[{"given":"Gabriela","family":"Soto-Canetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1113-4891","authenticated-orcid":false,"given":"Jordan","family":"Talia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2025.02.024_bib1","first-page":"e39553","article-title":"Role of anifrolumab in refractory cutaneous manifestations of lupus erythematosus: a case series and literature review","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jdcr.2025.02.024_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2020.1812201","article-title":"Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials","volume":"31","author":"Tanaka","year":"2021","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.02.024_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jdcr.2025.02.024_bib4","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/biomedicines11112904","article-title":"Anifrolumab for moderate and severe muco-cutaneous lupus erythematosus: a monocentric experience and review of the current literature","volume":"11","author":"Paolino","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdcr.2025.02.024_bib5","doi-asserted-by":"crossref","first-page":"1253279","DOI":"10.3389\/fimmu.2023.1253279","article-title":"Case report: response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in blood","volume":"14","author":"G\u00fcnther","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.02.024_bib6","doi-asserted-by":"crossref","first-page":"T55","DOI":"10.1016\/j.ad.2024.10.008","article-title":"[Translated article] Use of anifrolumab in systemic lupus erythematosus, cutaneous lupus erythematosus, and other autoimmune dermatoses. Article in English, Spanish","volume":"116","author":"Mart\u00edn-Torregrosa","year":"2025","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.jdcr.2025.02.024_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000910","article-title":"Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial","volume":"10","author":"Jayne","year":"2023","journal-title":"Lupus Sci Med"},{"issue":"2","key":"10.1016\/j.jdcr.2025.02.024_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamadermatol.2022.5242","article-title":"Treatment with anifrolumab for discoid lupus erythematosus","volume":"159","author":"Trentin","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.02.024_bib9","article-title":"Alopecia secondary to severe discoid lupus responding to anifrolumab","volume":"9","author":"Han","year":"2023","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.02.024_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001007","article-title":"Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE","volume":"10","author":"Bao","year":"2023","journal-title":"Lupus Sci Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:27:49Z","timestamp":1750163269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"alternative-id":["S2352512625000840"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.02.024","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive anifrolumab for recalcitrant discoid lupus erythematosus in the setting of systemic lupus erythematosus: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}